1. Translation and Validation of the Spanish Version of the SARC-F Questionnaire to Assess Sarcopenia in Older People.
- Author
-
Sánchez-Rodríguez, Dolores, Marco, E., Dávalos-Yerovi, V., López-Escobar, J., Messaggi-Sartor, M., Barrera, C., Ronquillo-Moreno, N., Vázquez-Ibar, O., Calle, A., Inzitari, M., Piotrowicz, K., Duran, X., Escalada, F., Muniesa, J. M., and Duarte, E.
- Subjects
ACADEMIC medical centers ,ELDER care ,CLINICS ,STATISTICAL correlation ,RESEARCH methodology ,MEDICAL societies ,QUESTIONNAIRES ,RESEARCH evaluation ,SELF-evaluation ,STATISTICS ,PREDICTIVE tests ,INDEPENDENT living ,DISEASE prevalence ,SARCOPENIA ,CROSS-sectional method ,RESEARCH methodology evaluation ,OLD age - Abstract
Objectives: The revised European consensus on sarcopenia definition and diagnosis (EWGSOP2) includes the SARC-F questionnaire, the most valid and consistent sarcopenia screening tool, as the mandatory first step. Our aim was the translation, cross-cultural adaptation, and validation of the SARC-F questionnaire as a culturally-responsive Spanish-language version for the European population. Study design: Cross-sectional descriptive study, applying the two-step WHO methodology for translation and cross-cultural adaptation of health questionnaires, and harmonization with the Mexican-Spanish version. European Union Geriatric Medicine Society recommendations for SARC-F validation in European languages were considered. Participants: Outpatient clinics of a university hospital. Inclusion criteria: stable, ambulatory (including aids), community-dwelling population ≥65 years old. Main outcome measures: The self-reported 5-item SARC-F questionnaire was administered; scores ≥4 indicated sarcopenia. Sensitivity, specificity, accuracy-likelihood ratios, predictive values, and kappa statistics were calculated and consecutively compared with European Working Group on Sarcopenia in Older People (EWGSOP) and EWGSOP2 criteria. Results: This Spanish version, administered in an average 70s, has adequate internal consistency (Cronbach alpha=0.779). For the validation study, 90 (43.3%) of 208 potentially eligible subjects (81.4 ± 5.9 years old, 75.6% women) were included. SARC-F identified 51 (56.7%) subjects with sarcopenia and 39 (43.3%) without the disease. Prevalence was 17.8% per EWGSOP and 25.6% per EWGSOP2 (58% accuracy and fair agreement: sensitivity, 783%; specificity, 50.8%). Conclusions: SARC-F is a feasible tool, suitable for bedside assessment in community-dwelling older patients. Wide diffusion of this culturally-responsible SARC-F Spanish version is expected as EWGSOP2 is adopted and sarcopenia assessment is broadly implemented in Spain. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF